MARKET ANALYSIS
The Chicago PE Firm Landscape
Chicago's private equity market has matured into one of the nation's most competitive. The metro area hosts roughly 350 to 400 active PE firms managing about $450 billion to $500 billion combined. That concentration places Chicago second only to New York in deal flow and sector depth. Healthcare leads at roughly 35% of deal activity, IT services and software follow at about 25%, and industrials and manufacturing capture another 20%. The median deal size has compressed from roughly $150 million five years ago to $90-$110 million today, reflecting economic headwinds and mega-funds abandoning mid-market territory. Growth equity shops have proliferated from roughly 40 firms in 2018 to nearly 120 today.
Healthcare dominates Chicago PE, reflecting the city's medical device heritage and depth of healthcare IT and services operators. Mayo Clinic's presence, Abbott Laboratories' operational footprint, and AbbVie's spin-off created layers of experienced operational talent that PE firms recruit and deploy. Healthcare deals in Chicago move faster than coastal markets because sourcing relationships are local and deep.
Financial services and software firms remain concentrated in Chicago, creating deal flow that benefits local PE. Companies seeking acquisition find Chicago-based PE firms to be knowledgeable counterparties. Software platforms and fintech companies raising capital find institutional support from investors familiar with the category.
Chicago's lower cost structure relative to New York or San Francisco means PE firms can target smaller check sizes and still generate attractive economics. This has created a wave of smaller PE and growth equity shops, increasing competition but also creating more capital availability for smaller founder-led businesses.